Panel Discussion: Reflections From Drug Developers: What Worked When Applying MIDD, What Didn’t & Why?
Time: 1:00 pm
day: Day 2
Details:
- Hear firsthand experiences on how MIDD strategies have successfully expedited clinical and regulatory milestones
- Explore common challenges and resistance factors that limited MIDD adoption, with advice on overcoming these obstacles
- Analyze retrospective case studies to identify best practices and lessons learned from embedding MIDD more effectively across development teams
